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Abstract
Pathogen genetics is already a mainstay of public health investigation and control efforts; now advances in technology
make it possible to investigate the role of human genetic variation in the epidemiology of infectious diseases. To describe
trends in this field, we analyzed articles that were published from 2001 through 2010 and indexed by the HuGE Navigator, a
curated online database of PubMed abstracts in human genome epidemiology. We extracted the principal findings from all
meta-analyses and genome-wide association studies (GWAS) with an infectious disease-related outcome. Finally, we
compared the representation of diseases in HuGE Navigator with their contributions to morbidity worldwide. We identified
3,730 articles on infectious diseases, including 27 meta-analyses and 23 GWAS. The number published each year increased
from 148 in 2001 to 543 in 2010 but remained a small fraction (about 7%) of all studies in human genome epidemiology.
Most articles were by authors from developed countries, but the percentage by authors from resource-limited countries
increased from 9% to 25% during the period studied. The most commonly studied diseases were HIV/AIDS, tuberculosis,
hepatitis B infection, hepatitis C infection, sepsis, and malaria. As genomic research methods become more affordable and
accessible, population-based research on infectious diseases will be able to examine the role of variation in human as well
as pathogen genomes. This approach offers new opportunities for understanding infectious disease susceptibility, severity,
treatment, control, and prevention.
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Introduction
Continually evolving human and environmental circumstanc-
es—including economic development, increased global travel and
commerce, and demographic and behavioral changes—have
contributed to the emergence of new infectious diseases and the
re-emergence of existing ones [1]. Ever-increasing global connect-
edness makes control of infectious diseases a global priority.
Pathogen genomics has become a leading tool for identifying
pathogens, tracking their spread and guiding public health
interventions [2,3].
Rapid advances in molecular technologies and informatics now
allow researchers to study human as well as pathogen genetic
variation in epidemiologic studies of infectious diseases. During the
last decade, population-based research on host genetic factors has
extended far beyond the traditional focus of such research on
human leukocyte antigens (HLAs) [4]. Although the pace of
human gene discovery has been brisk for common chronic diseases
and conditions, it has been slower for infectious diseases, which
accounted for only 23 of the 978 genome-wide association studies
(GWAS) published through 2010. We compiled and analyzed a
comprehensive database of published studies in human genome
epidemiology (HuGE) of infectious diseases to present a quanti-
tative summary of the field, including its current scope, focus, and
trends.
Methods
To assemble the set of published studies of human genetic
associations related to infectious diseases, we used a comprehen-
sive genetic association publications database, the Human
Genome Epidemiology (HuGE) Literature Finder (http://www.
hugenavigator.net). The HuGE Literature Finder contains articles
specifically related to human genome epidemiology, including
meta-analyses and systematic reviews, and also allows for filtering
of these articles on a number of criteria, including study type (e.g.,
observational study, meta-analysis), category (e.g., pharmacoge-
nomics, gene-environment interaction), gene, disease, and country
of first author. Since 2001, the database has been updated weekly
from PubMed (http://www.ncbi.nlm.nih.gov/pubmed) by a
combination of automated and human curation procedures [5].
This process has been shown to be highly sensitive (98.5%) and
highly specific (97.5%) for retrieval of genetic association articles
from PubMed [6].
To identify infectious disease-related articles in the HuGE
Literature Finder database, we developed two queries based on
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PubMed curators (http://www.nlm.nih.gov/mesh). One query
used four specific MeSH terms (‘‘bacterial diseases OR mycoses
OR virus diseases OR parasitic diseases’’) and one used two
general MeSH terms (‘‘infectious OR infection’’). We compared
the performance of the two queries in a subset of articles consisting
of those published in 2005 and 2006. Most of the articles identified
by the two queries were related to infectious diseases but the results
overlapped by only 68%; therefore, we used both queries for our
search.
We classified the subset of articles published between 2006 and
2010 (n=2,456) into five categories based on the relationship
between infection and the studied outcome: ‘‘infection as primary
outcome’’ (the association of one or more human genetic variants
with a specific infectious disease); ‘‘infection as a predisposing
factor’’ (genetic susceptibility to a chronic condition given
exposure to an infection); ‘‘infection as a complication’’ (genetic
susceptibility to infection given a pre-existing chronic condition or
predisposing event such as surgery or trauma); ‘‘genotype
prevalence’’ (population prevalence of genotypes known to be
associated with infectious diseases); and ‘‘pharmacogenomics in
treatment of infection.’’
To check the validity of our outcome classification by category,
we selected a random 10% sample of the articles published in
2006–2008 using the RAND() function in Excel version 2007. In
addition to the author, two reviewers (M. Gwinn and A.
Yesupriya) independently classified the articles in this sample
and any disagreements were resolved by discussion among the
three reviewers.
We estimated the sensitivity of our combined query for
infectious diseases by reviewing the title and abstract of every
tenth article excluded by the query for the period from 2006
through 2009. We multiplied by 10 to estimate the numbers of
false negative articles (i.e., related to infectious disease but missed
by the query) and true negative articles.
All subsequent data analyses were performed with use of SAS
version 9. We used a heuristic based on the textbook Genetic
Susceptibility to Infectious Diseases to classify genes into functional
categories (see Table S1) [7]. We used the HuGE Literature
Finder filter tool to identify infectious disease-related meta-
analyses and extracted the results. We used the National Human
Genome Research Institute’s Catalog of Published Genome-Wide
Association Studies (NHGRI Catalog) to identify all infectious
disease-related GWAS published from 2005 through 2010
(including those for diseases with only a suspected infectious
origin, such as Kawasaki disease). We extracted GWAS data
directly from the NHGRI Catalog, which includes only associa-
tions with a reported p level of 1610
25 or lower in the initial
GWAS and replication populations, reported either separately or
combined [8]. A list of references for all meta-analyses and GWAS
are found in the supplementary references.
To assess the alignment of research priorities with public health
burden, we examined the correlation of publication frequency (a
measure of research output) with disease-specific morbidity for 1)
the six most frequently studied infectious diseases; 2) the five most
frequently studied health conditions; and 3) the five leading causes
of morbidity worldwide. In this analysis, we also included key
chronic conditions often associated with one or more of the six
most frequently studied infectious diseases: liver cirrhosis, liver
cancer (hepatitis B and C infections), and gastric cancer (H. pylori
infections). The measure of morbidity we used was disability-
adjusted life years (DALYs), as calculated for the World Health
Organization’s Global burden of disease: 2004 update [9] (data file
available here: http://www.who.int/healthinfo/global_burden_
disease/estimates_regional/en/index.html). We chose morbidity
instead of mortality because human genetic factors have been
studied most frequently in infectious diseases with a chronic
course.
Results
Our queries selected 3,730 articles related to human genetic
epidemiology of infectious diseases indexed by the HuGE
Navigator from 2001–2010 [10]. The relationship of infection to
studied outcomes is summarized in Table 1. Approximately half of
the articles focused on infection as the primary outcome; another
20% studied genetic associations with infections as predisposing
factors for chronic conditions, such as liver fibrosis or cancer.
Approximately 14% of the articles selected by the query were not
related to infectious diseases—most often, their abstracts included
the keywords ‘‘infectious’’ or ‘‘infection’’ in background sentences
describing previous research. Thus, the estimated specificity of our
query was 86%.
Classifying a systematic sample of articles according to outcome
category, two independent reviewers agreed on 85% (116/137).
Through a resolution process, the other 21 articles were finally
classified as ‘‘Not related [to infectious disease]’’ (9 articles),
‘‘Infection as primary outcome’’ (6), ‘‘Pharmacogenomics in
treatment of infection’’ (2), ‘‘Infection as a predisposing factor’’
(2), or ‘‘Infection as a complication’’ (2).
A systematic 10% sample of articles published in 2006–2009
that were not selected by our query contained 2,722 articles,
including 21 articles related to infectious diseases. Thus, we
estimated that the query had an overall sensitivity of 89%. The
missed (false negative) articles included 10 on periodontitis, 4 on
rhinosinusitis, and 2 each on sepsis, leprosy, and tuberculosis.
None of these articles included the keywords ‘‘infectious’’ or
‘‘infection’’ in their titles or abstracts. Four missed articles were not
indexed with MeSH terms, including one written in a language
other than English. The remaining 17 articles were indexed with
MeSH terms that referred either to infectious organisms or to
clinical conditions such as ‘‘sinusitis’’ that are not cross-referenced
with infectious diseases in the MeSH thesaurus.
The annual number of publications related to infectious diseases
more than tripled from 148 in 2001 to 543 in 2010; however, the
percentage of all articles in the HuGE Literature Finder database
that were related to infectious diseases remained nearly constant
(range, 5.9–7.3%) (Figure 1). The most commonly studied
infectious diseases were human immunodeficiency virus/acquired
immune deficiency syndrome (HIV/AIDS, 688 articles), hepatitis
C virus (HCV, 410), Helicobacter pylori (H. pylori) infection (399),
tuberculosis (289), hepatitis B virus (HBV, 285), sepsis (254), and
malaria (199). Overall, cytokine receptor genes were the most
frequently studied category. Among individual genes, TNF and
HLA-DRB1 were studied most often, followed by IL10, CCR5,
IL1B, and HLA-B; each of these genes appeared in more than 200
gene-disease association studies (Tables S2 and S3).
Selected results from the 27 published meta-analyses are
summarized in Tables S4, S5, and S6. Six meta-analyses included
cohort studies; of these, three were related to HIV/AIDS and were
published in 2001 and 2003 (Table S5). Sixteen meta-analyses
included only case-control studies (Table S4). Most of these had a
combined sample size of more than 2,000 case subjects and more
than 2,000 control subjects. The reported odds ratios (ORs)
ranged from 1.09 to 2.58 for harmful effects and from 0.90 to 0.12
for protective effects. Of the five meta-analyses related to
pharmacogenomics, three included clinical trials (Table S6).
Three pharmacogenomics meta-analyses (one on anti-tuberculosis
Human Genome Epidemiology of Infectious Diseases
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produced statistically significant results, with ORs from 1.73 to
4.28.
Results reported from the 23 infectious disease-related GWAS
are summarized in Table S7. Eight of these studies focused on
HIV infection or progression to AIDS; four on treatment of HCV
infection and viral clearance; one on the role of host genetics in
determining susceptibility to atherosclerosis among HIV-infected
men on highly active antiretroviral therapy (HAART); and three
on chronic diseases with possible infectious agent origins
(Kawasaki disease, nasopharyngeal carcinoma, and IgA nephrop-
athy). The other seven GWAS focused on leprosy susceptibility,
severe malaria in children, chronic hepatitis B infection,
hepatocellular carcinoma (two studies), tuberculosis susceptibility,
and meningococcal disease susceptibility. The distribution of effect
sizes for significant GWAS results is shown in Figure 2.
Approximately one-third of the ORs were between 1.0 and 1.5,
one-third were between 1.51 and 2.0, and one-third were greater
than 2.0.
The five countries with the most publications from 2001
through 2010 were the United States, China, Japan, United
Kingdom, and Germany (Figure 3). Together, they accounted for
nearly half of all articles for which the first author’s country of
residence was known. Five additional countries each produced
more than 100 publications during this period: Brazil (158
articles), Italy (157), Spain (140), India (131), and South Korea
(103). The most frequently studied diseases varied considerably by
country. In China, 145 of 524 (28%) focused on HBV; in the
United States, 186 of 576 (33%) focused on HIV/AIDs; and in
Japan, 109 of 314 (35%) focused on H. pylori infection.
Although infectious diseases are leading causes of morbidity
worldwide—accounting for 280 million disability-adjusted life
years lost (DALYs) annually—they are relatively underrepresented
in human genome epidemiologic research (Figure 4). Only HIV/
AIDS, which alone accounted for almost 55 million DALYs in
2004, was represented by more than 500 publications during
2001–2010. In contrast, the most frequently studied diseases
together accounted for fewer than 82 million disability-adjusted
life years (DALYs) lost in 2004.
Discussion
Since the 19
th century, scientists and clinicians have sought
explanations for the extensive variation in clinical phenotypes
Table 1. Articles related to infectious diseases by studied outcome, HuGE Navigator, 2006–2010.
Article category n (%) Example topics
Infection as primary outcome 1173 (48) HIV to AIDS progression, malaria susceptibility
Infection as predisposing factor 493 (20) H. pylori and gastric cancer risk, HPV and cervical cancer risk
Pharmacogenomics in treatment of infection 217 (9) Nevirapine adverse effects in patients with HLA-B*3505allele
Infection as complication 169 (7) Sepsis after traumatic injury, pneumonia in cystic fibrosis patients
Gene prevalence 64 (3) Frequency of CRP genotypes in ethnic groups in Africa
Not related 340 (14) multiple sclerosis, chronic fatigue syndrome (where infection not studied)*
Total 2456 (100)
doi:10.1371/journal.pone.0025431.t001
Figure 1. Trend in publication of infectious disease-related articles in human genome epidemiology, 2001–2010.
doi:10.1371/journal.pone.0025431.g001
Human Genome Epidemiology of Infectious Diseases
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e25431among individuals infected by the same agent. Evidence has been
mounting since the 1930s that human genetics may play an
important role in this variation [11,12]. Results from several twin
studies support the hypothesis that genetic factors contribute to
variations in individual susceptibility to premature death from
infectious diseases, as well as to variations in vaccine response [13].
Results of a 2008 study of mortality data for multiple generations
of Utah families provided convincing evidence of a heritable
predisposition to death from influenza [14].
Results of the Human Genome Project and attendant
developments in molecular technology and informatics have
enhanced the study of human genetic factors in infectious disease
at the population level. The HuGE Navigator database, which has
grown rapidly since collection of published studies began in 2001,
comprised more than 50,000 articles by the end of 2010. We
found that the number of articles related to infectious diseases has
increased at roughly the same pace as the total number of articles
and still accounts for just 7% of the total.
Figure 2. Distribution of effect sizes for infectious disease-related GWAS as reported in the NHGRI Catalog, 2001–2010. One outlying
association with an OR of 27.1 (IL28B and HCV treatment; Tanaka 2009) is not shown.
doi:10.1371/journal.pone.0025431.g002
Figure 3. Five countries with the largest numbers of infectious disease-related publications in human genome epidemiology
(HuGE), 2001–2010.
doi:10.1371/journal.pone.0025431.g003
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exploring the role of human genetics in infectious diseases; in
particular, research on immune processes has suggested many
candidate genes for further study. We found more than 300 genes
whose association with infectious diseases had been studied more
than once. The genes most commonly studied were those
encoding tumour necrosis factors, cytokine receptors, HLA Class
II molecules, and chemokine receptors and their ligands.
Our review of published meta-analyses found many significant
genetic associations with infectious diseases; however, statistically
significant heterogeneity was found in half the studies that
reported testing for it. This heterogeneity could reflect the effects
of combining studies that were conducted in populations with
different genetic backgrounds (ancestry), or that used different
methods for genotyping (selecting and measuring genetic markers)
or phenotyping (diagnosing infection and defining clinical
outcomes).
The GWAS approach—based on hypothesis-free, systematic
genome scanning—has uncovered additional candidate genetic
associations with infectious diseases. Some are biologically
plausible, such as the association of IL28B with spontaneous viral
clearance in HCV infection [15]. Others have implicated
previously unexplored regions, such as 1p13.3, 9q23, and 8q22.3
in association with AIDS progression [16].
One possible reason for the relative scarcity of infectious
disease-related GWAS is the challenge of obtaining large enough
study populations with homogeneous phenotypes [17]. For
example, the first infectious disease-related GWAS was conducted
with 486 HIV-infected patients selected from a potentially eligible
group of 30,000 [18]. This study identified two HLA-associated
polymorphisms associated with HIV-1 control; however, their
replication in an independent cohort did not meet the GWAS
Catalog’s criterion for statistical significance (p,10
25) [8]—
probably because the second cohort included only 140 patients.
Both associations have been replicated in subsequent GWAS and
confirmed by meta-analysis, which increases effective sample size
by pooling the results of multiple studies.
Several other approaches have been proposed to discover
additional genetic associations relevant to infectious diseases; these
include systematic examinations of the entire major histocompat-
ibility (MHC) region and of the set of approximately 1,000 genes
involved in innate immunity [19]. Fellay et al. recently suggested
an approach for identifying rare variants (not detectable by
GWAS) by whole-genome sequencing of a small sample for gene
discovery, followed by testing of any associated variants in a larger
cohort [20]. Public health surveillance systems offer a potential
source of such cohorts [21].
Human genome epidemiologic research on infectious diseases is
a global enterprise. We found that the first authors of articles
published from 2001–2010 were from 104 countries. Together,
the United States, China, Japan, the United Kingdom, and
Germany accounted for half of all publications, with China taking
the lead after 2007. Our data provide only a minimum estimate of
global research output in this field because they are derived from
PubMed, which consists mostly of articles written in English.
The most frequently studied infections tended to vary by
country, perhaps reflecting these countries’ public health priorities.
For example, approximately one-third of the articles from the
United States, where more than 30,000 new HIV cases have been
diagnosed each year since 2005, were related to HIV/AIDS [22].
Nearly one-third of the articles from China, where approximately
8% of people are chronic HBV carriers, focused on HBV infection
Figure 4. Selected infectious and chronic diseases according to worldwide morbidity (disability-adjusted life-years, DALYs) and
publication frequency in human genome epidemiology (HuGE), 2001–2010. Solid black circles represent the six most frequently studied
infectious diseases; open black circles represent three chronic diseases that are often part of the natural course of infection with HBV, HCV, or H.
Pylori. Gray diamonds represent the four most frequently studied diseases overall. Gray squares represent the four diseases with the greatest
morbidity worldwide; the fifth is HIV/AIDS, represented with a blue dot. ›
doi:10.1371/journal.pone.0025431.g004
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health problems related to H. pylori infection, which is a significant
public health concern in a country where gastric cancer rates are
among the highest in the world [24].
HIV/AIDS was the most frequently studied infection and also
the largest contributor to global morbidity from infectious diseases
(about 55 million DALYs in 2004) [9]. Tuberculosis and malaria
each accounted for about 30 million DALYs—nearly twice the
number attributed to any of the diseases studied most often for
genetic associations (breast cancer, diabetes, Alzheimer’s disease,
schizophrenia, or lung cancer). In contrast to these adult-onset
conditions, infectious diseases affect people of all ages, which
accounts in part for their high impact when measured in DALYs.
Although developing countries have the highest rates of
morbidity and mortality from infectious diseases, most lack the
capacity to conduct human genomics research [25]. In our
analysis, Brazil and India ranked among the top 10 countries in
numbers of publications; however, 66 of the 104 countries with
authors in our database accounted for 10 or fewer articles.
Although a few developing countries have built impressive
biotechnology infrastructures, most have not, nor have they
benefitted from genomic research conducted elsewhere [25]. This
lack of participation in genomic research of infectious diseases by
countries with high rates of infectious disease indicates a need for a
collaborative global effort to support the participation of limited-
resource countries in such research. Such collaboration is also
important for ethical reasons, so that countries participating in
research also share in the benefits [26].
Analysis of pathogen genomics has become a mainstay of public
health approaches to surveillance, investigation, and control of
infectious diseases. For example, analysis of pathogen restriction-
fragment length polymorphism has been used since the 1980s to
identify epidemic strains and describe transmission patterns, and
genetic changes in influenza viruses are being closely monitored
for the emergence of strains with pandemic potential [27].
Researchers are currently investigating the use of additional
genomic techniques to improve surveillance of food-borne
pathogens [28,29] and enhance food safety, e.g., by determining
safe thresholds of contaminants for vulnerable population sub-
groups [29]. Advancements in informatics have led to the
development of crucial resources such as continuously updated
online databases; one example is the National Center for
Biotechnology Information’s Entrez Genome database, which
contains complete sequence data for more than 1,000 microbes
(http://www.ncbi.nlm.nih.gov/sites/entrez).
Studying the role of human genetics in infectious diseases offers
new opportunities to understand the etiology and pathology of
these diseases by exploring in more depth the determinants of
variation in susceptibility, clinical course, and mortality [12]. The
path from gene discovery to public health benefit may be more
clear-cut for infectious diseases than for many other health
conditions [30]; for example, studies of the role of human genetics
in infectious diseases have created the new field of vaccinomics,
which focuses on predicting vaccine response and avoiding
vaccine-related adverse events [31]. Research on both human
and pathogen genomes has the potential to identify novel vaccine
candidates more quickly than traditional methods of vaccine
candidate identification [3]. Better understanding of host-patho-
gen genome interactions has also encouraged research in
innovative therapies to limit and decrease the clinical severity of
infections [32].
In our review of human genetic epidemiologic studies since
2001, we found that HIV/AIDS was the most commonly studied
infectious disease. The search for human genetic variants that
influence HIV infection actually began in the early 1980s, not long
after the human immunodeficiency virus was identified. In 2004,
Stephen J. O’Brien of the U.S. National Cancer Institute, a
pioneer in this research, wrote, ‘‘Although AIDS is not generally
considered a genetic disease, the considerable heterogeneity in the
epidemic is at least partially determined by variants in genes that
moderate virus replication and immunity’’ [33]. CCR5 delta32,
discovered in 1996, was only the first of many variants found in
epidemiologic cohorts to be associated with HIV infection and
AIDS progression. Discovery that an intact CCR5 receptor is an
important co-factor in HIV infection has led to targeted drug and
vaccine development efforts [33,34].We found that 7% of articles
on genetic associations published from 2001 through 2010 focused
on infectious diseases—a disproportionately small fraction, given
their public health importance. As genomic research methods
become more affordable and accessible, human genome epidemi-
ology will help increase our understanding of people’s susceptibil-
ity to infectious diseases; the likely severity of these diseases; and
how best to prevent, control, and treat them.
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